Captopril for Refractory Hypertension in Patients with Chronic Renal Failure and Renal Transplantation
- 1 May 1981
- journal article
- other
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 74 (5) , 357-362
- https://doi.org/10.1177/014107688107400507
Abstract
The converting-enzyme inhibitor, Captopril, was given to ten patients with refractory severe hypertension of renal origin: 6 patients had chronic renal failure, 3 patients had hypertension following renal transplantation, and one patient had hypertension and congestive cardiac failure. Control of blood pressure was achieved with doses from 75 to 400 mg/day. Severe hyperkalemia occurred in one patient, ageusia (dose dependent) in another, and one patient withdrew from treatment because of nausea.This publication has 22 references indexed in Scilit:
- CAPTOPRIL AND FRUSEMIDE IN SEVERE DRUG-RESISTANT HYPERTENSIONThe Lancet, 1980
- COMBINED TREATMENT OF SEVERE INTRACTABLE HYPERTENSION WITH CAPTOPRIL AND DIURETICThe Lancet, 1980
- CAPTOPRIL ASSOCIATED GRANULOCYTOPENIA IN HYPERTENSION AFTER RENAL TRANSPLANTATIONThe Lancet, 1980
- NEPHROTIC SYNDROME IN PATIENT ONThe Lancet, 1979
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.Hypertension, 1979
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- INNAPPROPRIATE RENIN SECRETION UNMASKED BY CAPTOPRIL (SQ 14 225) IN HYPERTENSION OF CHRONIC RENAL FAILUREThe Lancet, 1978
- MINOXIDIL IN RESISTANT HYPERTENSIONThe Lancet, 1977
- (With Special Reference to Histocompatibility Matching, Thymectomy, Homograft Glomerulonephritis, Heterologous ALG, and Recipient Malignancy)Annals of Surgery, 1970